1. Home
  2. ESQ vs MLYS Comparison

ESQ vs MLYS Comparison

Compare ESQ & MLYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ESQ
  • MLYS
  • Stock Information
  • Founded
  • ESQ 2006
  • MLYS 2019
  • Country
  • ESQ United States
  • MLYS United States
  • Employees
  • ESQ N/A
  • MLYS N/A
  • Industry
  • ESQ Commercial Banks
  • MLYS Biotechnology: Pharmaceutical Preparations
  • Sector
  • ESQ Finance
  • MLYS Health Care
  • Exchange
  • ESQ Nasdaq
  • MLYS Nasdaq
  • Market Cap
  • ESQ 756.3M
  • MLYS 1.0B
  • IPO Year
  • ESQ 2017
  • MLYS 2023
  • Fundamental
  • Price
  • ESQ $95.62
  • MLYS $14.63
  • Analyst Decision
  • ESQ Hold
  • MLYS Strong Buy
  • Analyst Count
  • ESQ 3
  • MLYS 4
  • Target Price
  • ESQ $99.00
  • MLYS $27.00
  • AVG Volume (30 Days)
  • ESQ 176.5K
  • MLYS 885.1K
  • Earning Date
  • ESQ 07-24-2025
  • MLYS 08-12-2025
  • Dividend Yield
  • ESQ 0.72%
  • MLYS N/A
  • EPS Growth
  • ESQ 13.51
  • MLYS N/A
  • EPS
  • ESQ 5.27
  • MLYS N/A
  • Revenue
  • ESQ $124,132,000.00
  • MLYS N/A
  • Revenue This Year
  • ESQ N/A
  • MLYS N/A
  • Revenue Next Year
  • ESQ $10.72
  • MLYS N/A
  • P/E Ratio
  • ESQ $18.53
  • MLYS N/A
  • Revenue Growth
  • ESQ 14.72
  • MLYS N/A
  • 52 Week Low
  • ESQ $51.48
  • MLYS $8.24
  • 52 Week High
  • ESQ $101.35
  • MLYS $18.38
  • Technical
  • Relative Strength Index (RSI)
  • ESQ 53.09
  • MLYS 54.08
  • Support Level
  • ESQ $95.58
  • MLYS $14.07
  • Resistance Level
  • ESQ $101.28
  • MLYS $14.70
  • Average True Range (ATR)
  • ESQ 3.08
  • MLYS 0.69
  • MACD
  • ESQ -0.19
  • MLYS 0.15
  • Stochastic Oscillator
  • ESQ 47.07
  • MLYS 80.69

About ESQ Esquire Financial Holdings Inc.

Esquire Financial Holdings Inc is a financial holding company. Through its subsidiary, the company operates as a full-service commercial bank dedicated to serving the financial needs of the legal industry and small businesses nationally, as well as commercial and retail customers in the New York metropolitan area. The Bank offers tailored products and solutions to the legal community and their clients as well as dynamic and flexible payment processing solutions to small business owners. Banking products offered for businesses and consumers include checking, savings, money market, and time deposits; a wide range of commercial and consumer loans, as well as customary banking services. In addition, it operates a payment processing platform through third-party independent sales organizations.

About MLYS Mineralys Therapeutics Inc.

Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, typically including a diuretic.

Share on Social Networks: